Pharmacokinetic comparisons of berberine and palmatine in normal and metabolic syndrome rats

Journal of Ethnopharmacology

Volumn 151, Issue 1, 2014, Pages 287-291

  Liu, Qing Feng ^a   Shi, Xiao Jin ^a   Li, Zhong Dong ^a   Zhong, Ming Kang ^a   Jiao, Zheng ^a   Wang, Bin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Berberine; Metabolic syndrome; Palmatine; Pharmacokinetics; San Huang formula extract

Indexed keywords

BERBERINE; PALMATINE; PLANT MEDICINAL PRODUCT; SAN HUANG EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHINESE MEDICINE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; DRUG UPTAKE; ELECTROSPRAY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; METABOLIC SYNDROME X; NONHUMAN; PHARMACOKINETICS; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALIA; RATTUS;

BERBERINE; METABOLIC SYNDROME; PALMATINE; PHARMACOKINETICS; SAN-HUANG FORMULA EXTRACT;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BERBERINE; BERBERINE ALKALOIDS; DRUGS, CHINESE HERBAL; HALF-LIFE; MALE; METABOLIC SYNDROME X; MOLECULAR STRUCTURE; RANDOM ALLOCATION; RATS;

EID: 84891494342     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.10.031     Document Type: Article

References (27)

1. K.V. Anis, N.V. Rajeshkumar, and R. Kuttan Inhibition of chemical carcinogenesis by berberine in rats and mice J. Pharm. Pharmacol. 53 2001 763 768
2. Y.T. Deng, Q.F. Liao, S.H. Li, K.S. Bi, B.Y. Pan, and Z.Y. Xie Simultaneous determination of berberine, palmatine and jatrorrhizine by liquid chromatography-tandem mass spectrometry in rat plasma and its application in a pharmacokinetic study after oral administration of coptis-evodia herb couple J. Chromatogr. B 863 2008 195 205
3. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey Circulation 87 2002 356 359
4. D.F. Gu, K. Reynolds, W.J. Yang, S.F. Chen, X.G. Wu, X.F. Duan, X.D. Pu, L.H. Xu, X.P. Wu, X.F. Chen, R.M. Wei, N.L. Chen, T.Y. Wu, L.G. Wang, C.L. Yao, J.J. Mu, Y.F. Ma, S.M. Haffner, R.A. Valdez, H.P. Hazuda, B.D. Mitchell, P.A. Morales, and M.P. Stern The prevalence of metabolic syndrome in the general adult population aged 35-74 years in China Chin. J. Diabetes 13 2005 181 186
5. S.M. Haffner, R.A. Valdez, H.P. Hazuda, B.D. Mitchell, P.A. Morales, and M.P. Stern Prospective analysis of the insulin-resistance syndrome (syndrome X) Diabetes 41 1992 715 722
6. R.N. Hardwick, C.D. Fisher, S.M. Street, M.J. Canet, and N.J. Cherrington. Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis Drug Metab. Dispos. 40 2012 450 460
7. W.Y. Hua, L. Ding, Y. Chen, B. Gong, J.C. He, and G.L. Xu Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry J. Pharm. Biomed. Anal. 44 2007 931 937
8. Z. Huang, L. Wang, S. Meng, Y. Wang, T. Cheng, and C. Wang Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages Int. J. Cardiol. 146 2011 153 158
9. N.M. Kaplan The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension Arch. Intern. Med. 149 1989 1514 1520
10. Y.M. Kim, Y.M. Ha, Y.C. Jin, L.Y. Shi, Y.S. Lee, H.J. Kim, H.G. Seo, J.S. Choi, Y.S. Kim, S.S. Kang, J.H. Lee, and K.C. Chang Palmatine from Coptidis Rhizoma reduces ischemia-reperfusion-mediated acute myocardial injury in the rat Food Chem. Toxicol. 47 2009 2097 2102
11. C.L. Kuo, C.C. Chou, and B.Y.M. Yung Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells Cancer Lett. 93 1995 193 200
12. W.C. Lee, J.K. Kim, J.W. Kang, W.Y. Oh, J.Y. Jung, Y.S. Kim, H.A. Jung, J.S. Choi, and S.M. Lee Palmatine attenuates-galactosamine/lipopolysaccharide- induced fulminanthepatic failure in mice Food Chem. Toxicol. 48 2010 222 228
13. F.Q. Liu, Z.D. Li, X.J. Shi, and M.K. Zhong Determination of berberine, palmatine and jatrorrhizine in rabbit plasma by liquid chromatography- electrospray ionization-mass spectrometry J. Pharm. Biomed. Anal. 56 2011 1006 1015
14. F.Q. Liu, Z.D. Li, J. Liu, X.J. Shi, and M.K. Zhong Determination of astragaloside IV in Sanhuang mixture by HPLC-ELSD J. Pharm. Biomed. Anal. 56 2010 1006 1015
15. T. Lu, Y. Liang, J. Song, L. Xie, G.J. Wang, and X.D. Liu Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method J. Pharm. Biomed. Anal. 40 2006 1218 1224
16. B.L. Ma, M.K. Yao, J. Zhong, Y.M. Ma, C.L. Gao, J.S. Wu, F.R. Qiu, C.H. Wang, and X.H. Wang Increased systemic exposure to Rhizoma Coptidis alkaloids in lipopolysaccharide-pretreated rats attributable to enhanced intestinal absorption Drug Metab. Dispos. 40 2012 381 388
17. J.F. Pan, C. Yu, D.Y. Zhu, H. Zhang, J.F. Zhang, S.H. Jiang, and J.Y. Ren Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers' urine after oral administration Acta Pharmacol. Sin. 23 2002 77 82
18. X.J. Qiu, X. Huang, Z.Q. Chen, P. Ren, W. Huang, F. Qin, S.H. Hu, J. Huang, J. He, Z.Q. Liu, and H.H. Zhou Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia J. Ethnopharmacol. 137 2011 205 213
19. P. Ren, X. Huang, and S.Q. Li Pharmacokinetic characteristics of ferulic acid in patients with different syndromes of deficiency of spleen qi, stagnation of liver qi and spleen deficiency, and excess of stomach heat J. Chin. Integr. Med. 4 2006 147 151
20. C. Schindler The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis Ther. Adv. Cardiovasc. Dis. 1 2007 7 26
21. R. Skilton Michael, P. Moulin, J.L. Terra, and F. Bonnet Associations between anxiety, depression, and the metabolic syndrome Biol. Psychiatry 62 2007 1251 1257
22. F.R. Stermitz, P. Lorenz, J.N. Tawara, L.A. Zenewicz, and K. Lewis Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor Proc. Natl. Acad. Sci. USA 97 2000 1433 1437
23. W.J. Wang Foundation and application of aggregation syndrome theory in traditional Chinese medicine J. Chin. Integr. Med. 5 2007 111 114
24. A.D. Wen, X. Huang, and Y.P. Jiang et al. Blood stasis in congestive heart failure bears relation with digoxin clinical pharmacokinetics J. Fourth Mililitary Med. Univ. 22 2001 631 634
25. X.X. Wu, J. Peng, B. Fan, and Y.H. Yu Pharmacokinetics of three alkaloids in Huanglianjiedu decoction in rat serum by LC-MS-MS China J. Chin. Mater. Med. 34 2009 1276 1280
26. L.Y. Xu, Z.D. Li, Q.F. Liu, X.J. Shi, and M.K. Zhong Determination of four components in Sanhuang decoction by HPLC Chin. J. Mod. Appl. Pharm. 28 2011 1135 1138
27. X.J. Zeng, and X.H. Zeng Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC Biomed. Chromatogr. 13 1999 442 444